Bio Pharma Dive
JUNE 18, 2021
The U.S. drugmaker is the latest to invest large sums of money in antibody-drug conjugates, following recent deals by Gilead, Merck and AstraZeneca.
World of DTC Marketing
JUNE 18, 2021
SKIMMERS SUMMARY: According to a GAO Report “Medicare Parts B and D and beneficiaries spent $560 billion on drugs from 2016 through 2018, $324 billion of which was spent on advertised drug” GAO’s review of four advertised drugs found that drug manufacturers changed their DTCA spending during key events, such as increasing spending when a drug was approved to treat additional conditions or decreasing spending following the approval of generic versions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JUNE 18, 2021
Compared to vaccines, development of antiviral drugs for the coronavirus has progressed more slowly, although data are expected soon from Merck, Pfizer and Atea.
BioSpace
JUNE 18, 2021
The data showed that both experimental therapies restored function in the cystic fibrosis transmembrane conductance regulator gene.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Drug Patent Watch
JUNE 18, 2021
Annual Drug Patent Expirations for CLARINEX Clarinex is a drug marketed by Merck Sharp Dohme and is included in five NDAs. It is available from two suppliers. There are four…. The post New patent expiration for Merck Sharp drug CLARINEX appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
JUNE 18, 2021
Japan’s Eisai has hit the jackpot with its first ever antibody-drug conjugate (ADC) drug candidate, attracting a licensing deal from Bristol-Myers Squibb that could top out at more than $3.1 billion. . BMS is making a hefty $650 million upfront payment to Eisai for global co-development and co-commercialisation rights to MORAb-202, which couples an anti-folate receptor alpha (FR?
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
JUNE 18, 2021
International Sushi Day takes place each year on June 18 to celebrate the traditional Japanese meal turned global phenomenon. Raw fish and rice, often enclosed in seaweed, has gained a strong foothold in the Western world over the last few decades, but not without initial doubts and skepticism. Here’s everything you need to know about Sushi’s history and the significance behind International Sushi Day.
Scienmag
JUNE 18, 2021
Credit: Dr. Eleonora Adami Singapore, 18 Jun 2021 – Scientists at Duke-NUS Medical School and National Heart Centre Singapore (NHCS), in collaboration with colleagues in Singapore and the UK, have shown that the human form of the signalling protein interleukin 11 (IL-11) has a damaging effect on human liver cells–overturning a prior hypothesis that it […].
Pharma Times
JUNE 18, 2021
POLQ inhibitors could be used to kill PARP inhibitor-resistant cancer cells
Scienmag
JUNE 18, 2021
Credit: University of California San Diego A hydrogel that forms a barrier to keep heart tissue from adhering to surrounding tissue after surgery was developed and successfully tested in rodents by a team of University of California San Diego researchers. The team of engineers, scientists and physicians also conducted a pilot study on porcine hearts, […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
JUNE 18, 2021
NHSX and Accelerated Access Collaborative (AAC) have backed 38 AI-driven research projects
Scienmag
JUNE 18, 2021
National Trends in Disability Employment (nTIDE) – issued semi-monthly by Kessler Foundation and the University of New Hampshire Credit: Kessler Foundation East Hanover, NJ. June 18, 2021. The May numbers for furloughed workers remained relatively steady, according to today’s National Trends in Disability Employment (nTIDE) COVID Update.
Pharma Times
JUNE 18, 2021
Axial spondyloarthritis affects approximately one in 200 people in the UK
Scienmag
JUNE 18, 2021
Credit: © Rafaël Almar et al., Nature Communications. By combining satellite data and digital models, the researchers have shown that coastal overtopping, and consequently the risk of flooding, is set to further accelerate over the 21st century, by up to 50-fold under a high emission global warming scenario, especially in the tropics. This increase is […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Times
JUNE 18, 2021
Xeljanz reduced the incidence of death or respiratory failure compared to placebo in hospitalised patients
Scienmag
JUNE 18, 2021
Credit: Sylvain Pincebourde Birds build nests to keep eggs and baby nestlings warm during cool weather, but also make adjustments in nest insulation in such a way the little ones can keep cool in very hot conditions. Mammals, such as rabbits or groundhogs, sleep or hibernate in underground burrows that provide stable, moderate temperatures and […].
XTalks
JUNE 18, 2021
RIND Snacks is a start-up that makes dried fruit snacks by upcycling parts of the fruit that would have been wasted otherwise. They recently announced that they raised $6.1 million in a Series A round of funding. The New York-based company saw their revenues grow five-fold in 2020 and anticipate that their sales will triple in 2021 when they launch a new chip later this year.
Scienmag
JUNE 18, 2021
Neuroinflammatory response-induced proteases impede the recovery process from brain injury; novel interactions between proteins (hevin and calcyon) help in the recovery of neurons in a mature brain Credit: Korea Institute of Science and Technology(KIST) Patients with brain injury (caused by stroke or trauma) primarily rely on rehabilitation therapy for recovery, as there are no other […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Outsourcing Pharma
JUNE 18, 2021
United BioSource received the 2021 Healthiverse Heroes Award for Life Sciences in recognition of its automated clinical trial patient outreach technology.
Scienmag
JUNE 18, 2021
A large-capacity anode material is developed for sodium-ion batteries by using low-cost silicone-based oil. This process, if commercialized, is expected to significantly reduce manufacturing costs Credit: Korea Institute of Science and Technology(KIST) Various automobile companies are preparing to shift from internal combustion (IC) engine vehicles to electric vehicles (EVs).
XTalks
JUNE 18, 2021
Despite increasing vaccinations, the need for COVID-19 treatments has not gone away, particularly in light of vaccine shortages and rising case numbers in some countries around the world. This is why Regeneron’s announcement of positive clinical trial results that show its antibody cocktail treatment can cut deaths among hospitalized patients is welcome news.
Scienmag
JUNE 18, 2021
The cryptocurrency boom deserves special attention from researchers to improve its security and efficiency Credit: IMDEA Software Institute Researchers from the research unit “Security and Privacy” at TU Wien (Lukas Aumayr and his supervisor Prof. Matteo Maffei) in collaboration with the IMDEA Software Institute (Prof. Pedro Moreno-Sanchez, previously postdoc at TU Wien) and the Purdue […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
NY Times
JUNE 18, 2021
Production problems and a brief pause on its use kept the one-dose vaccine from becoming the game changer that health officials across the country believed it would be.
Scienmag
JUNE 18, 2021
Credit: UCI School of Medicine Irvine, CA – June 18, 2021 – A new study paves the way for the development of next generation therapeutics for the prevention and treatment of Clostridioides difficile infection (CDI), the most frequent cause of healthcare-acquired gastrointestinal infections and death in developed countries. Published today in Nature Communications, the study […].
BioSpace
JUNE 18, 2021
Findings from the study suggest the oral JAK inhibitor tofacitinib could be a potential contender in the race to identify benefits for COVID-19 in already approved therapies.
Scienmag
JUNE 18, 2021
Credit: The Novo Nordisk Foundation Center for Biosustainability The population on Earth is increasingly growing and people are expected to live longer in the future. Thus, better and more reliable therapies to treat human diseases such as Alzheimer’s and cardiovascular diseases are crucial. To cope with the challenge of ensuring healthy ageing, a group of […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
pharmaphorum
JUNE 18, 2021
There are an estimated nine million carers in the UK, and their contributions to society, individually and as a group, are unparalleled. Nadine von Dongen and Antonella Porta remind us why carers are the unrecognised backbone of our society. Every day, carers look after some of the most vulnerable people around us, attending to their basic and complex needs and striving to enhance their quality of life.
Scienmag
JUNE 18, 2021
June 18, 2021 – An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure. Outcomes in the first series of patients managed with the new heart replacement pump in Auto-Mode are presented in the ASAIO Journal, official journal of the […].
BioPharma Reporter
JUNE 18, 2021
A judgement has been issued in the legal dispute between the European Commission and AstraZeneca over a shortfall of delivery of the companyâs COVID-19 vaccine doses to the EU-27.
Scienmag
JUNE 18, 2021
New information about how different cosmic rays arrive at Earth hints at unique sources or propagation methods for different elements New findings published this week in Physical Review Letters suggest that carbon, oxygen, and hydrogen cosmic rays travel through the galaxy toward Earth in a similar way, but, surprisingly, that iron arrives at Earth differently. […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
345 
Let's personalize your content